Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status

Published on May 18, 2020in BMC Cancer3.15
· DOI :10.1186/S12885-020-06908-Z
Ilona Dudka2
Estimated H-index: 2
(Umeå University),
Elin Thysell14
Estimated H-index: 14
(Umeå University)
+ 6 AuthorsGerhard Gröbner26
Estimated H-index: 26
(Umeå University)
Sources
Abstract
BACKGROUND: Prostate cancer (PC) can display very heterogeneous phenotypes ranging from indolent asymptomatic to aggressive lethal forms. Understanding how these PC subtypes vary in their striving for energy and anabolic molecules is of fundamental importance for developing more effective therapies and diagnostics. Here, we carried out an extensive analysis of prostate tissue samples to reveal metabolic alterations during PC development and disease progression and furthermore between TMPRSS2-ERG rearrangement-positive and -negative PC subclasses. METHODS: Comprehensive metabolomics analysis of prostate tissue samples was performed by non-destructive high-resolution magic angle spinning nuclear magnetic resonance (1H HR MAS NMR). Subsequently, samples underwent moderate extraction, leaving tissue morphology intact for histopathological characterization. Metabolites in tissue extracts were identified by 1H/31P NMR and liquid chromatography-mass spectrometry (LC-MS). These metabolomics profiles were analyzed by chemometric tools and the outcome was further validated using proteomic data from a separate sample cohort. RESULTS: The obtained metabolite patterns significantly differed between PC and benign tissue and between samples with high and low Gleason score (GS). Five key metabolites (phosphocholine, glutamate, hypoxanthine, arginine and α-glucose) were identified, who were sufficient to differentiate between cancer and benign tissue and between high to low GS. In ERG-positive PC, the analysis revealed several acylcarnitines among the increased metabolites together with decreased levels of proteins involved in β-oxidation; indicating decreased acyl-CoAs oxidation in ERG-positive tumors. The ERG-positive group also showed increased levels of metabolites and proteins involved in purine catabolism; a potential sign of increased DNA damage and oxidative stress. CONCLUSIONS: Our comprehensive metabolomic analysis strongly indicates that ERG-positive PC and ERG-negative PC should be considered as different subtypes of PC; a fact requiring different, sub-type specific treatment strategies for affected patients.
📖 Papers frequently viewed together
19 Citations
2012
1 Author (Xueqing Zhao)
References60
Newest
#1Marouane KdadraH-Index: 1
#2Sebastian HöcknerH-Index: 1
Last. Eric SchifferH-Index: 27
view all 5 authors...
Prostate cancer (PCa) diagnosis with current biomarkers is difficult and often results in unnecessary invasive procedures as well as over-diagnosis and over-treatment, highlighting the need for novel biomarkers. The aim of this review is to provide a summary of available metabolomics PCa biomarkers, particularly for clinically significant disease. A systematic search was conducted on PubMed for publications from July 2008 to July 2018 in accordance with PRISMA guidelines to report biomarkers wit...
18 CitationsSource
#1Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 119
#1Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 18
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 6 authors...
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer...
31.7k CitationsSource
#1Rohit Mehra (UM: University of Michigan)H-Index: 71
#2Simpa S. Salami (UM: University of Michigan)H-Index: 12
Last. Scott A. Tomlins (UM: University of Michigan)H-Index: 85
view all 12 authors...
We have previously demonstrated a significant correlative relationship between PTEN deletion and ERG rearrangement, both in the development of clinically localized prostate cancers and metastases. Herein, we evaluate the cooperative role of ERG and PTEN in oncological outcomes after radical prostatectomy for clinically localized prostate cancer. We evaluated ERG and PTEN status using three previously described cohorts. The first cohort included 235 clinically localized prostate cancer cases repr...
11 CitationsSource
#1Jing-Yan Tian (JLU: Jilin University)H-Index: 1
#2Feng-Jun Guo (JLU: Jilin University)H-Index: 1
Last. Aamir Ahmad (WSU: Wayne State University)H-Index: 73
view all 4 authors...
Prostate cancer is the most common cancer in men by way of diagnosis and a leading cause of cancer-related deaths. Early detection and intervention remains key to its optimum clinical management. This review provides the most updated information on the recent methods of prostate cancer screening, imaging and treatment modalities. Wherever possible, clinical trial data has been supplemented to provide a comprehensive overview of current prostate cancer research and development. Considering the re...
17 CitationsSource
#1Tamara Jamaspishvili (Queen's University)H-Index: 10
#2David M. Berman (Queen's University)H-Index: 52
Last. Tamara L. Lotan (Johns Hopkins University)H-Index: 40
view all 7 authors...
Genomic aberrations of the PTEN tumour suppressor are among the most common in prostate cancer. In this Review, the authors describe the roles of PTEN, consider how PTEN status could act as a potential prognostic and predictive biomarker, and discuss the potential of PTEN and its downstream pathways as a therapeutic target.
192 CitationsSource
#1Jaden D. Evans (Mayo Clinic)H-Index: 10
#2Krishan R. Jethwa (Mayo Clinic)H-Index: 9
Last. Brian J. Davis (Mayo Clinic)H-Index: 37
view all 7 authors...
Abstract Prostate cancer–specific positron emission tomography (pcPET) has been shown to detect sites of disease recurrence at serum prostate-specific antigen (PSA) levels that are lower than those levels detected by conventional imaging. Commonly used pcPET radiotracers in the setting of biochemical recurrence are reviewed including carbon 11/fludeoxyglucose 18 (F-18) choline, gallium 68/F-18 prostate-specific membrane antigen (PSMA), and F-18 fluciclovine. Review of the literature generally fa...
87 CitationsSource
#1Eric Eidelman (UMB: University of Maryland, Baltimore)H-Index: 3
#2Jeffrey Twum-Ampofo (UMB: University of Maryland, Baltimore)H-Index: 1
Last. M. Minhaj Siddiqui (UMB: University of Maryland, Baltimore)H-Index: 27
view all 4 authors...
Prostate cancer is the most common non-cutaneous cancer in men in the United States. Cancer metabolism has emerged as a contemporary topic of great interest for improved mechanistic understanding of tumorigenesis. Prostate cancer is a disease model of great interest from a metabolic perspective. Prostatic tissue exhibits unique metabolic activity under baseline conditions. Benign prostate cells accumulate zinc and this excess zinc inhibits citrate oxidation and metabolism within the citric acid ...
89 CitationsSource
#1David M. Schuster (Emory University)H-Index: 33
#2Cristina Nanni (UNIBO: University of Bologna)H-Index: 54
Last. Stefano Fanti (UNIBO: University of Bologna)H-Index: 83
view all 3 authors...
Conventional anatomical imaging with CT and MRI has limitations in the evaluation of prostate cancer. PET is a powerful imaging technique, which can be directed toward molecular targets as diverse as glucose metabolism, density of prostate-specific membrane antigen receptors, and skeletal osteoblastic activity. Although 2-deoxy-2- 18 F-FDG-PET is the mainstay of molecular imaging, FDG has limitations in typically indolent prostate cancer. Yet, there are many useful and emerging PET tracers beyon...
45 CitationsSource
#1Tao Huan (U of A: University of Alberta)H-Index: 19
#2Dean A. Troyer (EVMS: Eastern Virginia Medical School)H-Index: 24
Last. Liang Li (U of A: University of Alberta)H-Index: 180
view all 3 authors...
Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer
18 CitationsSource
#1Ailin Falkmo Hansen (NTNU: Norwegian University of Science and Technology)H-Index: 7
#2Elise Sandsmark (NTNU: Norwegian University of Science and Technology)H-Index: 7
Last. May-Britt TessemH-Index: 20
view all 12 authors...
// Ailin Falkmo Hansen 1 , Elise Sandsmark 1 , Morten Beck Rye 2, 3, 4 , Alan J. Wright 5 , Helena Bertilsson 2, 4 , Elin Richardsen 6 , Trond Viset 7 , Anna M. Bofin 8 , Anders Angelsen 1 , Kirsten M. Selnaes 1 , Tone Frost Bathen 1 , May-Britt Tessem 1 1 Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway 2 Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University...
13 CitationsSource
Cited By7
Newest
#1Zhixian Liu (Nanjing Medical University)
#2Zhilan Zhang (CPU: China Pharmaceutical University)
Last. Xiaosheng Wang (CPU: China Pharmaceutical University)H-Index: 21
view all 4 authors...
Background TMPRSS2 is a host cell membrane fusion protein for SARS-CoV-2 invading human host cells. It also has an association with cancer, particularly prostate cancer. However, its association with lung cancer remains insufficiently explored. Thus, an in-depth investigation into the association between TMPRSS2 and lung cancer is significant, considering that lung cancer is the leading cause of cancer death and that the lungs are the primary organ SARS-CoV-2 attacks. Methods Using five lung ade...
Source
#1Ilona Dudka (Umeå University)H-Index: 2
#2Angelika Chachaj (Wrocław Medical University)H-Index: 8
Last. Andrzej Szuba (Wrocław Medical University)H-Index: 34
view all 7 authors...
Abstract In this pilot study, we carried out metabolic profiling of patients with rheumatoid arthritis (RA) starting therapy with biological disease-modifying antirheumatic drugs (bDMARDs). The main aim of the study was to assess the occurring metabolic changes associated with therapy success and metabolic pathways involved. In particular, the potential of the metabolomics profiles was evaluated as therapeutically valuable prognostic indicators of the effectiveness of bDMARD treatment to identif...
1 CitationsSource
#1Masahiro Sogabe (University of Tokushima)H-Index: 11
#2Toshiya Okahisa (University of Tokushima)H-Index: 17
Last. Tetsuji Takayama (University of Tokushima)H-Index: 33
view all 13 authors...
Background Erosive esophagitis (EE) is strongly associated with metabolic syndrome (MS), but is not always recognized in individuals with MS and the prevalence of EE in individuals with non-MS is not low. Aim To examine the differences in clinical factors associated with EE at various stages of MS, as well as the differences in metabolites between subjects with MS, with and without EE. Methods A total of 7,097 persons who underwent health checkups including esophagogastroduodenoscopy were analyz...
Source
#1Ana Rita LimaH-Index: 6
#2Joana PintoH-Index: 17
Last. Paula Guedes de PinhoH-Index: 39
view all 6 authors...
Prostate cancer (PCa) is the second most diagnosed cancer in men worldwide. For its screening, serum prostate specific antigen (PSA) test has been largely performed over the past decade, despite its lack of accuracy and inability to distinguish indolent from aggressive disease. Metabolomics has been widely applied in cancer biomarker discovery due to the well-known metabolic reprogramming characteristic of cancer cells. Most of the metabolomic studies have reported alterations in urine of PCa pa...
2 CitationsSource
#1Christian Fohringer (SLU: Swedish University of Agricultural Sciences)H-Index: 1
#2Ilona Dudka (Umeå University)H-Index: 2
Last. Navinder Singh (SLU: Swedish University of Agricultural Sciences)H-Index: 8
view all 9 authors...
With accelerated land conversion and global heating at northern latitudes, it becomes crucial to understand, how life histories of animals in extreme environments adapt to these changes. Animals may either adapt by adjusting foraging behavior or through physiological responses, including adjusting their energy metabolism or both. Until now, it has been difficult to study such adaptations in free-ranging animals due to methodological constraints that prevent extensive spatiotemporal coverage of e...
1 CitationsSource
#1Maria Karoline Andersen (NTNU: Norwegian University of Science and Technology)H-Index: 4
#2Therese Stork Høiem (NTNU: Norwegian University of Science and Technology)H-Index: 2
Last. May-Britt Tessem (NTNU: Norwegian University of Science and Technology)H-Index: 20
view all 13 authors...
BACKGROUND Prostate cancer tissues are inherently heterogeneous, which presents a challenge for metabolic profiling using traditional bulk analysis methods that produce an averaged profile. The aim of this study was therefore to spatially detect metabolites and lipids on prostate tissue sections by using mass spectrometry imaging (MSI), a method that facilitates molecular imaging of heterogeneous tissue sections, which can subsequently be related to the histology of the same section. METHODS Her...
4 CitationsSource
The combined effects of global warming and land use changes experienced by animals at high latitudes, are poorly understood. Social and eco-physiological perspectives are therefore necessary to elucidate where and when animals and the ecosystems they represent are most vulnerable to environmental change. This requires integration of multiple disciplines, application of novel and established methods as well as data, to achieve a holistic understanding of accumulating impacts of global change. In ...